Literature DB >> 18029382

Cardiac resynchronization therapy in left ventricular hypertrabeculation/non-compaction and myopathy.

Claudia Stöllberger1, Gerhard Blazek, Elisabeth Bucher, Josef Finsterer.   

Abstract

AIMS: Little is known how patients with left ventricular hypertrabeculation/non-compaction (LVHT) and heart failure respond to cardiac resynchronization therapy (CRT). METHODS AND
RESULTS: Included in this retrospective study were 8/102 patients (3 female, age range 43-78 years), in whom LVHT was diagnosed and in whom a CRT system was implanted. All eight patients were investigated neurologically and in seven of them a myopathy was found. The mean follow-up after CRT implantation was 39 (4-68) months. All patients improved by one or more New York Heart Association (NYHA) classes, and two by two NYHA classes. The left ventricular end-diastolic diameter decreased by < or =5% in 2 patients, by 6-10% in 3 patients, by 12% in 1 patient, and by >30% in 2 patients. The left ventricular systolic function, as assessed by the fractional shortening, did not change in 2 patients, increased by 10% in 2 patients, by 59% in 1 patient, doubled in 2 patients, and showed a five-fold increase in 1 patient. Two patients died during follow-up.
CONCLUSION: CRT by biventricular pacing in LVHT, heart failure, and myopathy leads to improvement in functional capacity in all patients and improvement of systolic function in half of the patients. The weak response of LVHT patients to CRT may be due to inappropriate selection or comorbidities, in particular, neuromuscular disorders.

Entities:  

Mesh:

Year:  2007        PMID: 18029382     DOI: 10.1093/europace/eum245

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  7 in total

1.  Left ventricular hypertrabeculation/noncompaction, cardiac phenotype, and neuromuscular disorders.

Authors:  C Stöllberger; C Wegner; J Finsterer
Journal:  Herz       Date:  2018-04-06       Impact factor: 1.443

2.  Effects of cardiac resynchronization therapy on left ventricular remodeling and dyssynchrony in patients with left ventricular noncompaction and heart failure.

Authors:  Qiong Qiu; Yang-xin Chen; Jing-ting Mai; Wo-liang Yuan; Yu-lin Wei; Ying-mei Liu; Li Yang; Jing-Feng Wang
Journal:  Int J Cardiovasc Imaging       Date:  2014-11-13       Impact factor: 2.357

Review 3.  Left Ventricular Noncompaction Cardiomyopathy and Recurrent Polymorphic Ventricular Tachycardia: A Case Report and Literature Review.

Authors:  Oluwaseun A Akinseye; Uzoma N Ibebuogu; Sunil K Jha
Journal:  Perm J       Date:  2017

Review 4.  Left ventricular non-compaction and its cardiac and neurologic implications.

Authors:  Josef Finsterer
Journal:  Heart Fail Rev       Date:  2010-11       Impact factor: 4.214

5.  Response to cardiac resynchronization therapy in non-ischemic cardiomyopathy is unrelated to medical therapy.

Authors:  Gregory Sinner; Hesham R Omar; You W Lin; Samy C Elayi; Maya E Guglin
Journal:  Clin Cardiol       Date:  2018-12-15       Impact factor: 2.882

Review 6.  Cardiac Resynchronization Therapy in Non-Ischemic Cardiomyopathy.

Authors:  Miriam Shanks; Victoria Delgado; Jeroen J Bax
Journal:  J Atr Fibrillation       Date:  2016-02-29

7.  Cardiac and neuromuscular implications of left bundle branch block in left ventricular hypertrabeculation/noncompaction.

Authors:  C Stöllberger; G Blazek; M Winkler-Dworak; J Finsterer
Journal:  Can J Cardiol       Date:  2009-03       Impact factor: 5.223

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.